A lead extraction procedure commenced to remove a right ventricular (rv) and a left ventricular (lv) lead due to non function.Spectranetics lld ez lead locking devices (lld ezs) were inserted into each lead to provide traction.Beginning with a spectranetics 14f glidelight laser sheath on the lv lead, advancement was made only into the subclavian when the lv lead released.Next, using the same 14f glidelight and a spectranetics visisheath dilator sheath, the rv lead was extracted without issues, and a new rv lead was re-implanted.Then, while preparing for the new lv lead re-implantation, the patent's blood pressure dropped and a posterior effusion was detected (not present when lv lead was extracted), via transesophageal echocardiography (tee).Rescue efforts began, including a pericardial window, and a small, lateral cardiac vein perforation was suspected.A clot was removed, and a drain was placed.The patient survived the procedure.This report captures the lld providing traction within the lv lead, when the suspected perforation occurred, requiring intervention.There was no alleged malfunction of any spectranetics devices in use during the procedure.
|
H3): the device was discarded, thus no investigation could be completed.H6): perforation of vessels is a known risk of complication with use of the lld.Submission of this report does not, in itself, represent a conclusion by the manufacturer and/or authorized representative or the national competent authority that the content of this report is complete or accurate, that the medical device(s) listed failed in any manner and/or that the medical device(s) caused or contributed to an alleged death or deterioration in the state of the health of any person.
|